A Lilly USA LLC employee fired for allegedly misusing a corporate credit card failed to mount a viable claim that he was ...

We came across a bullish thesis on Eli Lilly and Company (LLY) on Substack by Kontra Investments. In this article, we will ...

We recently published a list of Jim Cramer Discusses These 11 Stocks & President Trump’s Sovereign Wealth Fund. In this ...

Real-time index price for S&P Smallcap 600 (IQY), along with buy or sell indicators, analysis, charts, historical performance, news and more ...

In Novo Nordisk's home country of Denmark, Wegovy costs only $186 a month. It should surprise no one that 72% of the ...

Indeed, the company's pipeline is impressive overall. What to Expect From Blockbuster GLP-1 Treatments Much of Eli Lilly's momentum in recent quarters has been due to Mounjaro and Zepbound.

Eli Lilly started 2024 on a strong note but ... Since the approval of Vertex's first CF medicine in 2012, no other company has cracked this code, despite plenty of them trying.

2025 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) will announce its fourth-quarter 2024 financial results and 2025 financial guidance on Feb. 6, 2025. Lilly will also conduct a conference ...

In this article, we are going to take a look at where Eli Lilly and Company (NYSE:LLY) stands against the other large-cap value stocks. The market outlook is as uncertain as it gets. On January 18 ...

The stage may be set for a reversal or move higher. Next: Access Our New, Shockingly Simple 'Alert System' Shares of Eli Lilly and Company LLY are trading higher after getting pummeled on Friday.

Bank of America Securities analyst Tim Anderson maintained a Buy rating on Eli Lilly & Co (LLY – Research Report) today. The company’s shares closed last Friday at $725.72. According to ...

In the recent years, companies like Novo Nordisk and Eli Lilly have GLP-1 agonists and dual GLP-1/GIP receptor agonists that have shown drastic impact in treating obesity. This year, revolutionary ...